It is a nonreceptor tyrosine kinase overexpressed in more than 60% of breast cancer cases, and EGFR-regulated signaling is impaired in these cancers, which significantly increases MAPK activity and thus leads to fast proliferation and migration of breast cancer cells [49]. Here, EGFR is linked to breast carcinoma.